Yuta Yoshino1, Taku Yoshida1, Takaaki Mori1, Shigeru Hirota2, Junichi Iga1, Shu-ichi Ueno1. 1. Department of Neuropsychiatry,Molecules and Function,Ehime University Graduate School of Medicine,Shitsukawa,Toon,Ehime 791-0295,Japan. 2. Department of Psychiatry,Futaiwa Hospital,4-160-1,Wakayama,Yawatahama,Ehime 796-8035,Japan.
Abstract
BACKGROUND: The mean age of inpatients with schizophrenia has gradually increased in Japan and the risk of fracture in older schizophrenia patients is elevated. One possible cause may be idiopathic normal pressure hydrocephalus (iNPH). The present study aimed to evaluate the prevalence and symptoms of iNPH in older inpatients with schizophrenia. METHODS: We prospectively examined older inpatients with schizophrenia (N = 21, mean age = 70.5 ± 5.9) in a psychiatric ward. We evaluated iNPH symptoms using the idiopathic Normal-Pressure Hydrocephalus Grading Scale (iNPHGS), Timed Up-and-Go test (TUG), Gait Status Scale (GSS), Mini-Mental State Examination (MMSE), and Neuropsychiatric Inventory (NPI). We also evaluated symptoms of schizophrenia using the Brief Psychiatric Rating Scale (BPRS) and Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). We conducted cerebrospinal fluid (CSF) tap tests for patients with possible-iNPH. RESULTS: In total, three (14.3%) patients were diagnosed with possible iNPH: age, GS-Gait, GS-Cognition, TUG, 10-meter walking test, GSS, and DIEPSS were significantly increased in these compared to patients without iNPH; however, GS-Urine, MMSE, NPI, and BPRS did not differ significantly. Probable iNPH was diagnosed for two (9.5%) patients because of positive CSF tap tests. CONCLUSION: The prevalence of possible and probable iNPH in older patients with schizophrenia was much higher than that reported for older people without mental illness. Of the symptoms evaluated with the tests employed, only gait disturbances, particularly walking speed, distinguished schizophrenia patients with iNPH. These findings suggest that we should pay more attention to the possibility of iNPH in older patients with schizophrenia.
BACKGROUND: The mean age of inpatients with schizophrenia has gradually increased in Japan and the risk of fracture in older schizophreniapatients is elevated. One possible cause may be idiopathic normal pressure hydrocephalus (iNPH). The present study aimed to evaluate the prevalence and symptoms of iNPH in older inpatients with schizophrenia. METHODS: We prospectively examined older inpatients with schizophrenia (N = 21, mean age = 70.5 ± 5.9) in a psychiatric ward. We evaluated iNPH symptoms using the idiopathic Normal-Pressure Hydrocephalus Grading Scale (iNPHGS), Timed Up-and-Go test (TUG), Gait Status Scale (GSS), Mini-Mental State Examination (MMSE), and Neuropsychiatric Inventory (NPI). We also evaluated symptoms of schizophrenia using the Brief Psychiatric Rating Scale (BPRS) and Drug-Induced Extrapyramidal Symptoms Scale (DIEPSS). We conducted cerebrospinal fluid (CSF) tap tests for patients with possible-iNPH. RESULTS: In total, three (14.3%) patients were diagnosed with possible iNPH: age, GS-Gait, GS-Cognition, TUG, 10-meter walking test, GSS, and DIEPSS were significantly increased in these compared to patients without iNPH; however, GS-Urine, MMSE, NPI, and BPRS did not differ significantly. Probable iNPH was diagnosed for two (9.5%) patients because of positive CSF tap tests. CONCLUSION: The prevalence of possible and probable iNPH in older patients with schizophrenia was much higher than that reported for older people without mental illness. Of the symptoms evaluated with the tests employed, only gait disturbances, particularly walking speed, distinguished schizophreniapatients with iNPH. These findings suggest that we should pay more attention to the possibility of iNPH in older patients with schizophrenia.
Entities:
Keywords:
cerebrospinal fluid tap test; normal pressure hydrocephalus; schizophrenia
Authors: Tina Nørgaard Munch; Paula Louise Hedley; Christian Munch Hagen; Marie Bækvad-Hansen; Jonas Bybjerg-Grauholm; Jakob Grove; Merete Nordentoft; Anders Dupont Børglum; Preben Bo Mortensen; Thomas Mears Werge; Mads Melbye; David Michael Hougaard; Michael Christiansen Journal: J Neurodev Disord Date: 2021-04-28 Impact factor: 4.025
Authors: Vasco Vanhala; Antti Junkkari; Ville E Korhonen; Mitja I Kurki; Mikko Hiltunen; Tuomas Rauramaa; Ossi Nerg; Anne M Koivisto; Anne M Remes; Jonna Perälä; Jaana Suvisaari; Soili M Lehto; Heimo Viinamäki; Hilkka Soininen; Juha E Jääskeläinen; Ville Leinonen Journal: Neurosurgery Date: 2019-04-01 Impact factor: 4.654